The first COVID-19 vaccine has received emergency use authorization. Yet a key question remains: Will U.S. adults be willing to get it? A new study led by a Virginia Commonwealth University professor is...

By NewsDesk  @bactiman63 In a statement Friday from Susan R. Bailey, M.D., President, American Medical Association (AMA), she says the following: “For much of this year, physicians, nurses and frontline...

By NewsDesk  @bactiman63 On Friday, the U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused...

By NewsDesk  @bactiman63 Canadian health officials announced Wednesday the authorization of the first COVID-19 vaccine. Health Canada has determined that the Pfizer-BioNTech vaccine meets the Department’s...

A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers...

By NewsDesk  @bactiman63 Flaviviruses — a group of viruses transmitted by ticks or mosquitoes — infect an estimated 400 million people annually with diseases like yellow fever, Dengue fever,...

Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against Covid-19 based on the yellow fever vaccine, which as a result also works against yellow fever. Results...

By NewsDesk  @bactiman63 Specialty vaccine company, Valneva SE, announced yesterday its plans to accelerate pediatric development of its Lyme vaccine candidate, VLA15, in collaboration with Pfizer Inc.,...

By NewsDesk   @bactiman63 Pfizer Inc. and BioNTech SE announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency...

By NewsDesk  @bactiman63 An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study...